cushing's%20syndrome
CUSHING'S SYNDROME
Cushing’s syndrome is a condition which is due to prolonged exposure of the body tissue to excess cortisol (glucocorticoid hormone).
Laboratory tests and radiological findings confirm diagnosis and determine the actual cause of Cushing's syndrome.
Endogenous adrenocorticotropic hormone (ACTH)-independent Cushing's syndrome has adrenal hypersecretion due to adrenal adenoma, adrenal carcinoma, micronodular hyperplasia, and macronodular hyperplasia.
Exogenous ACTH-independent Cushing's syndrome has adrenal hypersecretion due to iatrogenic causes (eg drug-induced, corticosteroid use).

Surgical Intervention

Transsphenoidal Selective Adenomectomy

  • 1st-line therapy for Cushing’s disease
  • Usually performed after inferior petrosal sinus (IPS)
  • A potential cure which keeps pituitary function intact
  • Effects: Generally 80% cure rate (cortisol normalized or rendered hypoadrenal) after initial surgery
    • If 2nd surgery is necessary, it tends to be less successful
  • Different criteria for cure are used eg serum cortisol averaged from 5 readings taken in 1 day: 150-300 nmol/L
  • Patients will generally need glucocorticoid replacement therapy starting after surgery until the hypothalamic-pituitary-adrenal axis has recovered (4-12 months)
  • Complications: Hypopituitarism, diabetes insipidus

Adrenalectomy

  • Unilateral adrenalectomy
    • Cures adrenal adenoma & improves the prognosis of adrenal carcinoma
    • Possibility of remission for Cushing’s disease if pituitary radiotherapy is administered at the same time
  • Total bilateral adrenalectomy
    • A complete cure for adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome
    • Last-line therapy (for patients not cured by other surgical methods or pituitary radiotherapy)
    • May be needed for bilateral micronodular or macronodular hyperplasia
    • May be performed in malignant metastatic tumor of undiagnosed ectopic source
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 Jun 2015
Long-term oral testosterone undecanoate significantly improved IPSS quality of life scores in a 1-year, randomised, multicentre, double-blind trial among aging hypogonadal men.
Rachel Soon, 01 Jun 2016

The inclusion of statins in managing chronic kidney disease (CKD) may help reduce patient mortality from stroke and possibly other cardiovascular events, according to an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Rachel Soon, 01 Jun 2016

Patients with hypercholesterolaemia with unchanging LDL-cholesterol levels after 6 weeks of statin treatment should be actively assessed for either statin intolerance or resistance, says an expert at the 7th Malaysian Endocrine and Metabolic Society (MEMS) Annual Congress.

Prof. Cyrus Rustam Kumana, 07 Jul 2016

This case scenario was presented at a grand round in the Department of Medicine, The University of Hong Kong. Unlike traditional grand rounds that directly or indirectly deal with clinical challenges posed by patients, this one was equally about doctors and how they care for their charges. All doctors who tend patients dread being implicated on the receiving end of medico-legal proceedings. This topic is therefore intimately linked to the professionalism of doctors, their standing in the community, and the ethical aspects of how they interact with patients and relatives.